Sergio Balingit, MD
Sleep Medicine · The Villages, FLNPI 1669405312
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,701 of the $12,932 with a category attached, or 75.0%. 32 manufacturers reported payments, led by Intuitive Surgical at 24.6% of the total. Reporting peaked in 2023 at $5,000 and has fallen 53.7% since, to $2,313 in 2025.
Across 489 payments — averaging $26.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- GSK$2K
- Boehringer Ingelheim$1K
- AstraZeneca$1K
- Takeda Pharmaceuticals U.S.A., Inc.$903
- Grifols USA, LLC$409
- plus $3K from 26 others
What the payments were for
- Travel & lodging$1611%
- Food & beverage$9,70175%
- Education$3,07024%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $3,178 |
| GSK | 116 | $2,258 |
| Boehringer Ingelheim | 84 | $1,495 |
| AstraZeneca | 54 | $1,321 |
| Takeda Pharmaceuticals U.S.A., Inc. | 56 | $903 |
| Grifols USA, LLC | 20 | $409 |
| Mylan Specialty L.p. | 17 | $381 |
| Regeneron Healthcare Solutions, Inc. | 12 | $237 |
| Verona Pharma, Inc. | 15 | $233 |
| Baxter Healthcare | 10 | $231 |
| Sanofi | 10 | $222 |
| Pulmonx Corporation | 8 | $206 |
| Electromed, Inc. | 22 | $199 |
| Insmed, Inc. | 10 | $196 |
| Boston Scientific | 1 | $168 |
| Mallinckrodt Hospital Products Inc. | 8 | $160 |
| Abiomed | 1 | $146 |
| Avinger Inc. | 1 | $120 |
| Genentech USA, Inc. | 7 | $119 |
| Bayer | 1 | $114 |
| Advanced Respiratory, Inc | 5 | $96 |
| Edwards Lifesciences | 1 | $84 |
| Fisher & Paykel Healthcare Inc | 5 | $82 |
| Viatris Specialty LLC | 5 | $81 |
| Inogen, Inc. | 7 | $80 |
| Harmony Biosciences LLC | 2 | $67 |
| Inspire Medical Systems, Inc. | 2 | $45 |
| Abbott | 1 | $30 |
| Philips North America LLC | 1 | $23 |
| Resmed Corp | 1 | $18 |
| Body Vision Medical Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,155
- BREZTRI$212
- WATCHMAN FLX$168
- Impella$146
- AREXVY$121
- PANTHERIS$120
- Yupelri$119
- Kerendia$114
- TRELEGY ELLIPTA$100
- AIRSUPRA$100
How this compares
$12,932 in reported general payments places this provider in the 80th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 69 | $1,014,131 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 503 | $496,465 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 382 | $272,591 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 209 | $182,831 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 225 | $181,187 |
| Pirfenidone | 28 | $147,480 |
| Breo ElliptaFluticasone/Vilanterol | 108 | $67,802 |
| SymbicortBudesonide/Formoterol Fumarate | 146 | $54,559 |
| Spiriva RespimatTiotropium Bromide | 48 | $48,169 |
| Spiriva HandihalerTiotropium Bromide | 26 | $33,196 |
| Incruse ElliptaUmeclidinium Bromide | 30 | $14,996 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 17 | $12,969 |
| Bosentan | 11 | $12,795 |
| Advair HfaFluticasone Propion/Salmeterol | 19 | $9,563 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 304 | $8,845 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat | $1,495 | $1,245,131326 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $2,258 | $851,8541,023 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,321 | $248,715388 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 77 sleep medicine providers in Florida.
Other sleep medicine in The Villages
- Jeremy McConnellBradenton$615K
- Edward MezerhaneMiami$537K
- Shane DrahosWinter Garden$317K
- Kunal AgarwalSarasota$153K
- Camilo RuizFort Lauderdale$136K
- Sergio JaramilloMiami$32K
- Carlos Ramirez MejiaMiami$25K
- Luis OrtizSt Petersburg$24K
- Harneet WaliaMiami$19K
- Radhika VermaOrange City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.